Search
for
Sort by
Research 31–60 of 45
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Human umbilical cord mesenchymal stem cell therapy for atopic dermatitis through inhibition of neutrophil chemotaxis
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Sodium pentaborate pentahydrate promotes hair growth through the Wnt/β-catenin pathway and growth factors
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- A guide to diagnosis and management of hypertrichosis
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Vulvovaginal involvement in Netherton syndrome: A case report
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- 1,314
- Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study
- Heterozygous Variants of the SLC39A4 Gene and Possible Increased Risk for Developing Acrodermatitis Enteropathica with Kaposi’s Varicelliform Eruption
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Role of skin enzymes in metabolism of topical drugs
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- A prospective, interventional, randomized, open-label, comparative, three-arm, parallel allocation, single-center clinical study to evaluate the effectiveness of Venusia CeraPlus cream and lotion as an adjuvant in the treatment of atopic dermatitis